Laura Espana-Padilla
Distinguished in Cavernous Lymphangioma

Laura Espana-Padilla

Sevilla, AN, ES 
Distinguished in Cavernous Lymphangioma
Sevilla, AN, ES 
OverviewLocationsClinical Research

Overview

Laura Espana-Padilla practices in Sevilla, Spain. Ms. Espana-Padilla is rated as a Distinguished expert by MediFind in the treatment of Cavernous Lymphangioma. Her top areas of expertise are Cavernous Lymphangioma, Warts, Anal Cancer, and Genital Warts.

Her clinical research consists of co-authoring 40 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles in the study of Cavernous Lymphangioma.

Gender
Female

Locations

Sevilla, AN, Spain
Other Locations
Marbella, AN, Spain
Malaga, AN, Spain

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

40 Total Publications

Chronic infectious osteomyelitis: A diagnosis beyond the skin.
Chronic infectious osteomyelitis: A diagnosis beyond the skin.
Journal: Medicina clinica
Published: October 09, 2018

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Espana-Padilla's expertise for a condition
ConditionClose
    View All 11 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile